BioCatalystWatch
IONSWorkspace / IONS / OverviewCompany library
IONIS PHARMACEUTICALS INC logo

IONIS PHARMACEUTICALS INC

IONIS PHARMACEUTICALS INC (IONS)

Website

Price
Market cap
Next catalystAt AHA in November 2026; delivery not confirmedpelacarsen — Lp(a)HORIZON · Phase 3 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

obudanersen

UBE3A antisense transcript (UBE3A-ATS)

PreINDP1P2P3FilingApproved
Upcoming / outlook

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

obudanersen

UBE3A antisense transcript (UBE3A-ATS)

PreINDP1P2P3FilingApproved
Upcoming / outlook

PreINDP1P2P3FilingApproved

Other pipelines

ION775

APOC3

PreINDP1P2P3FilingApproved
ION269

APP

PreINDP1P2P3FilingApproved
ION717

PRNP

PreINDP1P2P3FilingApproved
ION337

PreINDP1P2P3FilingApproved
IONIS-ENAC-2.5Rx

Epithelial sodium channel (ENaC)

ION440

MECP2

PreINDP1P2P3FilingApproved
IONIS-ENAC-2.5Rx

Epithelial sodium channel (ENaC)

PreINDP1P2P3FilingApproved
ION356

PLP1

PreINDP1P2P3FilingApproved

Partner / License out

Apo(a)

PreINDP1P2P3FilingApproved
Upcoming / outlook

HBV RNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

PreINDP1P2P3FilingApproved

SMN2 pre-mRNA

Approved / commercial

FUS

PreINDP1P2P3FilingApproved
Upcoming / outlook

SOD1 mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Approved / commercial

APOC3 mRNA

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

History / paused

Complement factor B

PreINDP1P2P3FilingApproved

PCSK9

PreINDP1P2P3FilingApproved

Complement factor B (CFB)

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

IONS PR & News

PR & News

IONS SEC archive